X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3172) 3172
Newsletter (154) 154
Newspaper Article (81) 81
Book Chapter (36) 36
Magazine Article (15) 15
Government Document (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2103) 2103
life sciences & biomedicine (1985) 1985
humans (1629) 1629
male (1587) 1587
animals (1534) 1534
carbamates (1125) 1125
female (1036) 1036
carbamates - administration & dosage (873) 873
pharmacology & pharmacy (834) 834
carbamates - pharmacology (771) 771
carbamates - therapeutic use (703) 703
rats (686) 686
adult (593) 593
middle aged (555) 555
mice (437) 437
administration, oral (387) 387
dose-response relationship, drug (381) 381
carbamates - adverse effects (375) 375
carbamates - pharmacokinetics (352) 352
aged (351) 351
drug therapy, combination (345) 345
neurosciences & neurology (322) 322
analysis (315) 315
treatment outcome (282) 282
toxicology (281) 281
neurosciences (271) 271
chemistry (263) 263
time factors (263) 263
research (257) 257
physical sciences (240) 240
sulfonamides - administration & dosage (238) 238
carbamates - chemistry (223) 223
hiv infections - drug therapy (223) 223
drug interactions (222) 222
drug therapy (210) 210
benzamides - pharmacology (204) 204
piperidines - pharmacology (202) 202
rats, wistar (194) 194
sulfonamides - therapeutic use (193) 193
rats, sprague-dawley (189) 189
drug administration schedule (179) 179
pesticides (179) 179
adolescent (177) 177
abridged index medicus (176) 176
carbamates - toxicity (173) 173
piperidines - administration & dosage (171) 171
health aspects (159) 159
piperidines - therapeutic use (157) 157
amidohydrolases - antagonists & inhibitors (155) 155
repaglinide (155) 155
ritonavir - administration & dosage (153) 153
diabetes mellitus, type 2 - drug therapy (152) 152
disease models, animal (149) 149
genotype (145) 145
hepatitis c, chronic - drug therapy (145) 145
enzymes (143) 143
carbamates - metabolism (140) 140
clinical neurology (140) 140
carbamate (136) 136
care and treatment (136) 136
pharmacology/toxicology (136) 136
benzimidazoles - administration & dosage (134) 134
drug combinations (134) 134
double-blind method (133) 133
rodents (133) 133
sulfonamides - adverse effects (131) 131
biochemistry & molecular biology (130) 130
carbamates - blood (130) 130
antiviral agents - therapeutic use (129) 129
young adult (129) 129
hepatitis c (126) 126
hypoglycemic agents - administration & dosage (126) 126
antiviral agents - administration & dosage (125) 125
infectious diseases (124) 124
pharmacokinetics (123) 123
area under curve (121) 121
phenylcarbamates (121) 121
hepatitis c virus (120) 120
clinical trials as topic (119) 119
sulfonamides - pharmacokinetics (119) 119
enzyme inhibitors - pharmacology (118) 118
hepacivirus - genetics (118) 118
hypoglycemic agents - therapeutic use (117) 117
pharmacology (116) 116
hiv protease inhibitors - administration & dosage (115) 115
insecticides (115) 115
antiviral agents (112) 112
dosage and administration (112) 112
physiological aspects (112) 112
psychiatry (110) 110
ritonavir - therapeutic use (109) 109
piperidines - pharmacokinetics (108) 108
fatty acids (105) 105
internal medicine (103) 103
clinical trials (102) 102
medicine & public health (102) 102
structure-activity relationship (100) 100
endocannabinoids (99) 99
rivastigmine (99) 99
biomedicine (98) 98
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3312) 3312
Russian (58) 58
German (39) 39
Japanese (34) 34
French (12) 12
Polish (10) 10
Spanish (8) 8
Portuguese (7) 7
Bulgarian (5) 5
Chinese (4) 4
Slovak (4) 4
Czech (3) 3
Italian (3) 3
Dutch (2) 2
Hungarian (2) 2
Norwegian (2) 2
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of hepatology, ISSN 0168-8278, 12/2015, Volume 63, Issue 6, pp. 1511 - 1522
Summary Failure to respond to the approved combinations of multiple direct-acting antiviral agents is relatively low in hepatitis C virus treatment... 
Gastroenterology and Hepatology | Daclatasvir | Simeprevir | Treatment | Resistance-associated variants | Ledipasvir | Interferon | Hepatitis C virus | Sofosbuvir | Direct-acting antivirals | Resistanceassociated variants | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Carbamates - administration & dosage | Simeprevir - administration & dosage | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Treatment Failure | Protease Inhibitors - administration & dosage | Fluorenes - administration & dosage | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Interferons - administration & dosage | Drug Resistance, Viral - genetics | Anilides - administration & dosage | Sofosbuvir - administration & dosage | Uridine Monophosphate - analogs & derivatives | Macrocyclic Compounds - administration & dosage | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Development and progression | Protease inhibitors | Drug resistance | Hepatitis C | Proteases | Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 09/2016, Volume 151, Issue 3, pp. 457 - 471.e5
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2012, Volume 379, Issue 9835, pp. 2429 - 2438
Summary Background The HIV integrase strand transfer inhibitor elvitegravir (EVG) has been co-formulated with the CYP3A4 inhibitor cobicistat (COBI),... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV-1 | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Atazanavir Sulfate | Adult | Female | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Ritonavir - administration & dosage | Deoxycytidine - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Quinolones - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Antiviral agents | Patient outcomes | Dosage and administration | Research | Comparative analysis | Drug therapy | HIV infection | Anti-HIV agents | Antiretroviral drugs | Bone density | Pharmaceutical industry | Human immunodeficiency virus--HIV | Pneumonia | Laboratories | Ritonavir | Liver | Infections | Drug resistance | Evidence-based medicine | Hepatitis | Randomization | All terrain vehicles | Creatinine | Integrase | Data processing | Proteinase inhibitors | Behavior disorders | Ribonucleic acid--RNA | Patients | Cholesterol | Glomerular filtration rate | Protease inhibitors | Interactive systems | Index Medicus | Abridged Index Medicus
Journal Article
Journal of critical care, ISSN 0883-9441, 12/2016, Volume 36, pp. 116 - 124
Abstract Objectives The aim of this review was to evaluate current literature for dosing recommendations for the use of antiepileptic medications in patients... 
Critical Care | Anticonvulsants | Intensive care | Hemodialysis | Continuous renal replacement therapy | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Humans | Seizures - drug therapy | Critical Illness | Anticonvulsants - administration & dosage | gamma-Aminobutyric Acid - administration & dosage | Carbamates - administration & dosage | Phenylenediamines - administration & dosage | Seizures - complications | Dose-Response Relationship, Drug | Anticonvulsants - adverse effects | Phenobarbital - administration & dosage | Acute Kidney Injury - complications | Amines - administration & dosage | Dibenzazepines - administration & dosage | Renal Replacement Therapy | Cyclohexanecarboxylic Acids - administration & dosage | Isoxazoles - administration & dosage | Phenytoin - administration & dosage | Fructose - analogs & derivatives | Phenylcarbamates - administration & dosage | Valproic Acid - administration & dosage | Propylene Glycols - administration & dosage | Triazines - administration & dosage | Piracetam - analogs & derivatives | Piracetam - administration & dosage | Acute Kidney Injury - therapy | Ethosuximide - administration & dosage | Fructose - administration & dosage | Acetamides - administration & dosage | Renal Dialysis | Drugstores | Pharmacy | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 06/2017, Volume 66, Issue 6, pp. 1138 - 1148
Graphical abstract 
Gastroenterology and Hepatology | Antiviral agents | Ombitasvir | Ritonavir | Ledipasvir | Real-world | Genotype 1 | Paritaprevir | Sustained virologic response | Hepatitis C, Chronic | Sofosbuvir | Dasabuvir | Randomized controlled trials | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Neoplasm Recurrence, Local - etiology | Liver Neoplasms - etiology | Young Adult | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Drug Therapy, Combination | Glomerular Filtration Rate | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Spain | Anilides - administration & dosage | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Sulfonamides - administration & dosage | Cohort Studies | Uracil - analogs & derivatives | Genetic aspects | Safety and security measures | Hepatitis C virus | Clinical trials | Chronic infection | Data processing | Hepatocellular carcinoma | Multivariate analysis | Patients | Clinical outcomes | Ribavirin | Genotype & phenotype | Cohort analysis | Fibrosis | Safety | Drug therapy | Hepatitis C | Antiviral drugs | Genotypes | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9835, pp. 2439 - 2448
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 06/2016, Volume 150, Issue 7, pp. 1590 - 1598
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 11/2015, Volume 112, Issue 45, pp. 14084 - 14089
Marijuana exerts profound effects on human social behavior, but the neural substrates underlying such effects are unknown. Here we report that social contact... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Endocannabinoids - metabolism | Immunohistochemistry | Piperazines - administration & dosage | Bornanes - administration & dosage | Clozapine - administration & dosage | Nucleus Accumbens - metabolism | Bornanes - pharmacology | Male | Carbamates - administration & dosage | Oxytocin - metabolism | Receptors, Cannabinoid - metabolism | Arachidonic Acids - metabolism | Benzamides - administration & dosage | Clozapine - pharmacology | Piperidines - pharmacology | Social Behavior | Benzamides - pharmacology | Carbamates - pharmacology | Pyrazoles - pharmacology | Piperidines - administration & dosage | Benzodiazepines - pharmacology | Mice, Inbred C57BL | Clozapine - analogs & derivatives | Polyunsaturated Alkamides - metabolism | Piperazines - pharmacology | Cocaine - administration & dosage | Cocaine - pharmacology | Pyrazoles - administration & dosage | Animals | Analysis of Variance | Benzodiazepines - administration & dosage | Signal Transduction - physiology | Mice | Lipids - analysis | Reward | Infusions, Intraventricular | Autism Spectrum Disorder - physiopathology | Influence | Cellular signal transduction | Research | Oxytocin | Analysis | Endocannabinoids | Brain | Autism | Marijuana | Neurotransmitters | Neurons | Rodents | Index Medicus | reward | Biological Sciences | endocannabinoid | oxytocin | anandamide | social behavior
Journal Article